Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | Prevalence per 1,000 inhabitants |
|---|---|
| Finland | 4.57 |
| Sweden | 2.59 |
| Norway | 2.04 |
| Ireland | 1.75 |
| United Kingdom | 1.72 |
| Canada | 1.6 |
| Denmark | 1.56 |
| Iceland | 1.5 |
| Germany | 1.47 |
| Estonia | 1.43 |
| Australia | 1.41 |
| Netherlands | 1.39 |
| United States | 1.38 |
| Israel | 1.26 |
| Hungary | 1.26 |
| Spain | 1.25 |
| Czech Rep. | 1.24 |
| OECD35 | 1.23 |
| Austria | 1.22 |
| Russian Fed. | 1.14 |
| Poland | 1.11 |
| New Zealand | 1.09 |
| Luxembourg | 1.06 |
| Belgium | 1 |
| Slovenia | 0.98 |
| Brazil | 0.98 |
| Portugal | 0.95 |
| Lithuania | 0.94 |
| Switzerland | 0.89 |
| France | 0.86 |
| Slovak Rep. | 0.84 |
| Greece | 0.83 |
| Italy | 0.82 |
| Chile | 0.57 |
| Turkey | 0.5 |
| Mexico | 0.41 |
| Latvia | 0.33 |
| India | 0.28 |
| China | 0.19 |
| Japan | 0.16 |
| Colombia | 0.12 |
| Korea | 0.06 |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
November 2017
More information
Region
Worldwide
Survey time period
2015
Special properties
Aged between 0 and 14 years
Citation formats
